The conventional pathway, which accounts for 75–80% of all colorectal cancer diagnoses, is initiated by the biallelic inactivation of APC and progresses to cancer via mutations in KRAS and alterations to the TP53 gene. The gene discussed is APC; the disease is colorectal cancer.